MX2022011167A - Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. - Google Patents
Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana.Info
- Publication number
- MX2022011167A MX2022011167A MX2022011167A MX2022011167A MX2022011167A MX 2022011167 A MX2022011167 A MX 2022011167A MX 2022011167 A MX2022011167 A MX 2022011167A MX 2022011167 A MX2022011167 A MX 2022011167A MX 2022011167 A MX2022011167 A MX 2022011167A
- Authority
- MX
- Mexico
- Prior art keywords
- pathogens
- innate immune
- detection
- human milk
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 230000002708 enhancing effect Effects 0.000 title abstract 3
- 244000052769 pathogen Species 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title abstract 2
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 230000018041 innate immune response in mucosa Effects 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 4
- 235000016709 nutrition Nutrition 0.000 abstract 4
- SNFSYLYCDAVZGP-OLAZETNGSA-N 2'-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@H](O)[C@@H]1O SNFSYLYCDAVZGP-OLAZETNGSA-N 0.000 abstract 2
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 2
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 2
- 229940062780 lacto-n-neotetraose Drugs 0.000 abstract 2
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 2
- 229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Pediatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se divulga un método para mejorar la respuesta inmune innata de la mucosa de un individuo a los patógenos. El método incluye una etapa de administración de una composición nutricional al individuo. La composición nutricional incluye de cerca de 0.05 a cerca de 0.5 mg/mL de fucosillactosa-2' (2 '-FL), de cerca de 0.05 a cerca de 0.5 mg/mL de lacto-N neotetraosa (LNnT), o una combinación de ambos. También se divulga un método para mejorar la detección inmune innata de la mucosa del individuo de patógenos. El método incluye una etapa de administración una composición nutricional al individuo. La composición nutricional incluye un oligosacárido neutro de la leche humana.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461976791P | 2014-04-08 | 2014-04-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022011167A true MX2022011167A (es) | 2022-10-18 |
Family
ID=52988462
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016013064A MX2016013064A (es) | 2014-04-08 | 2015-04-03 | Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. |
MX2022011167A MX2022011167A (es) | 2014-04-08 | 2016-10-05 | Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016013064A MX2016013064A (es) | 2014-04-08 | 2015-04-03 | Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. |
Country Status (10)
Country | Link |
---|---|
US (1) | US10792294B2 (es) |
EP (2) | EP3673909A1 (es) |
CN (2) | CN113331426A (es) |
CA (2) | CA3179163A1 (es) |
HK (1) | HK1231398A1 (es) |
IL (1) | IL247465B (es) |
MX (2) | MX2016013064A (es) |
PH (1) | PH12016501974A1 (es) |
SG (1) | SG11201608248YA (es) |
WO (1) | WO2015157098A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11040050B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
US11040049B2 (en) | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
EP3212197A4 (en) | 2014-10-29 | 2018-07-11 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
WO2016139333A1 (en) | 2015-03-05 | 2016-09-09 | Nestec S.A. | Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children |
WO2016138911A1 (en) * | 2015-03-05 | 2016-09-09 | Glycom A/S | Composition and method for treating acute respiratory tract infections |
EP3368047B1 (en) * | 2015-10-28 | 2023-04-26 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
US10835545B2 (en) | 2015-10-28 | 2020-11-17 | Glycom A/S | Synthetic composition and method for modulating brain function and behaviour |
PL3377071T3 (pl) * | 2015-11-17 | 2024-06-24 | Glycom A/S | Oligosacharydy mleka ludzkiego do leczenia powikłań związanych z antybiotykami |
DK3452050T3 (da) * | 2016-05-05 | 2023-02-20 | Glycom As | Composition comprising hmos for the treatment of noninfectious diarrhoea |
US11224605B2 (en) | 2016-05-19 | 2022-01-18 | Glycom A/S | Synthetic composition |
WO2017215722A1 (en) * | 2016-06-15 | 2017-12-21 | Glycom A/S | Synthetic composition comprising hmo and method for modulating emotion and mood disorders |
PT3883393T (pt) | 2019-06-04 | 2022-12-07 | Nutricia Nv | Composição nutricional compreendendo 2'fucosilactose e butirato dietético |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6841543B1 (en) | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
RU2199317C2 (ru) | 1997-02-21 | 2003-02-27 | Абботт Лаборэтриз | Способ снижения заболеваемости некротическим энтероколитом у детей (варианты) |
US6045854A (en) | 1997-03-31 | 2000-04-04 | Abbott Laboraties | Nutritional formulations containing oligosaccharides |
EP1062873A1 (en) | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
US7893041B2 (en) * | 2003-12-05 | 2011-02-22 | Children's Hospital Medical Center | Oligosaccharide compositions and use thereof in the treatment of infection |
PL1993577T3 (pl) * | 2006-03-10 | 2014-07-31 | Nutricia Nv | Stosowanie nieulegających trawieniu sacharydów dla zapewnienia niemowlęciu najlepszego startu po narodzinach |
US8197872B2 (en) | 2007-05-17 | 2012-06-12 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
BRPI0820175B8 (pt) | 2007-11-08 | 2022-11-22 | Nestec Sa | uso de oligossacarídeos contendo n-acetillactosamina para maturação de respostas imunes em neonatos. |
EP2072052A1 (en) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prevention of opportunistic infections in immune-compromised subjects |
EP2451462B1 (en) | 2009-07-06 | 2017-09-06 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
RU2530641C2 (ru) * | 2009-07-15 | 2014-10-10 | Н.В. Нютрисиа | Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой |
EP2662084A1 (en) * | 2009-07-15 | 2013-11-13 | N.V. Nutricia | Mixture of non-digestible oligosaccharides for stimulating the immune system |
WO2011119023A1 (en) | 2010-03-26 | 2011-09-29 | N.V. Nutricia | Low protein infant formula with increased essential amino acids |
EP2465508A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
EP2465507A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2455387A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
EP2658546B1 (en) | 2010-12-31 | 2018-12-05 | Abbott Laboratories | Methods of using human milk oligosaccharides for improving airway respiratory health |
WO2012092156A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
CA2822660C (en) | 2010-12-31 | 2021-09-07 | Abbott Laboratories | Synbiotic combination of probiotic and human milk oligosaccharides |
EP3335576A1 (en) * | 2010-12-31 | 2018-06-20 | Abbott Laboratories | Human milk oligosaccharides to promote growth of beneficial bacteria |
MX352040B (es) * | 2010-12-31 | 2017-11-07 | Abbott Lab | Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. |
EP3338784B1 (en) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
CN107510040A (zh) | 2010-12-31 | 2017-12-26 | 雅培制药有限公司 | 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途 |
CN103379908B (zh) | 2010-12-31 | 2020-02-14 | 雅培制药有限公司 | 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法 |
CN103442696B (zh) | 2011-02-04 | 2016-09-21 | 加利福尼亚大学董事会 | 预防或抑制肠病的二唾液酸乳-n-四糖(dslnt)或其变体、异构体、类似物和衍生物 |
CN104126749A (zh) | 2011-02-10 | 2014-11-05 | 雀巢产品技术援助有限公司 | 使用人乳中发现的特定量的寡糖的组合调节双歧杆菌属的生长 |
WO2012158517A1 (en) | 2011-05-13 | 2012-11-22 | Glycosyn LLC | The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics |
US20130012472A1 (en) * | 2011-07-05 | 2013-01-10 | Boston College | Composition and methods of inhibiting gastrointestinal pathogen infection |
CN113662199A (zh) * | 2011-08-29 | 2021-11-19 | 雅培制药有限公司 | 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖 |
-
2015
- 2015-04-03 EP EP20158081.8A patent/EP3673909A1/en active Pending
- 2015-04-03 WO PCT/US2015/024205 patent/WO2015157098A1/en active Application Filing
- 2015-04-03 SG SG11201608248YA patent/SG11201608248YA/en unknown
- 2015-04-03 CA CA3179163A patent/CA3179163A1/en active Pending
- 2015-04-03 US US15/302,793 patent/US10792294B2/en active Active
- 2015-04-03 CN CN202110639783.8A patent/CN113331426A/zh active Pending
- 2015-04-03 CA CA2942732A patent/CA2942732C/en active Active
- 2015-04-03 CN CN201580015100.4A patent/CN106132420A/zh active Pending
- 2015-04-03 MX MX2016013064A patent/MX2016013064A/es unknown
- 2015-04-03 EP EP15717356.8A patent/EP3129030A1/en not_active Withdrawn
-
2016
- 2016-08-24 IL IL247465A patent/IL247465B/en active IP Right Grant
- 2016-10-04 PH PH12016501974A patent/PH12016501974A1/en unknown
- 2016-10-05 MX MX2022011167A patent/MX2022011167A/es unknown
-
2017
- 2017-05-22 HK HK17105161.3A patent/HK1231398A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1231398A1 (zh) | 2017-12-22 |
MX2016013064A (es) | 2017-01-26 |
WO2015157098A1 (en) | 2015-10-15 |
IL247465B (en) | 2020-11-30 |
CN113331426A (zh) | 2021-09-03 |
CN106132420A (zh) | 2016-11-16 |
US10792294B2 (en) | 2020-10-06 |
IL247465A0 (en) | 2016-11-30 |
CA2942732A1 (en) | 2015-10-15 |
PH12016501974A1 (en) | 2016-12-19 |
EP3129030A1 (en) | 2017-02-15 |
EP3673909A1 (en) | 2020-07-01 |
SG11201608248YA (en) | 2016-10-28 |
US20170020906A1 (en) | 2017-01-26 |
CA2942732C (en) | 2023-01-03 |
CA3179163A1 (en) | 2015-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022011167A (es) | Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana. | |
PH12018501221A1 (en) | Mixture of hmos | |
PH12021550318A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
WO2016033439A3 (en) | Compositions and methods for the treating an inflammatory disease or disorder | |
MX2022011742A (es) | Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados. | |
MY187609A (en) | Human milk oligosaccharides to ameliorate symptoms of stress | |
MY166946A (en) | Methods of using human milk oligosaccharides for improving airway respiratory health | |
PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
MY193660A (en) | Optimized nutrient food | |
PH12019500799A1 (en) | Personalized pediatric nutrition products comprising human milk oligosaccharides | |
MX2021013109A (es) | Proceso de preparacion de una vacuna tetravalente atenuada contra el virus del dengue. | |
PH12018500993A1 (en) | Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate | |
PH12016501879B1 (en) | Immunological composition containing attenuated histophilus somni | |
MX2016014346A (es) | Tratamiento de enfermedad de crohn con 6-mercaptopurina de liberacion prolongada. | |
MX2015012548A (es) | Metodos para estimular la maduracion de pulmones e intestinos infantiles. | |
PH12019500092A1 (en) | Nutritional compositions for infants and/or young children comprising oligosaccharides | |
WO2015159155A3 (en) | Novel ademetionine formulations | |
MY175269A (en) | Single high dose of mva induces a protective immune response in neonates and infants | |
PH12014501782A1 (en) | Maternal supplement to enhance immune system of an infant | |
Mekinian | Severe neutropenia: case report | |
Sangrador Pelluz | Non-immediate hypersensitivity reaction, managed with desensitisation: case report | |
UA64817U (ru) | Способ лечения больных синдромом повышенной усталости с использованием апипрепаратов |